LIPOPROTEIN DISORDER
Clinical trials for LIPOPROTEIN DISORDER explained in plain language.
Never miss a new study
Get alerted when new LIPOPROTEIN DISORDER trials appear
Sign up with your email to follow new studies for LIPOPROTEIN DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to slash 'Silent' heart risk in 204-Patient trial
Disease control Recruiting nowThis study tests an experimental drug called Kylo-11 in 204 adults with heart disease and high levels of lipoprotein(a), a genetic risk factor that standard treatments often miss. Participants receive either the drug or a placebo as a shot, and researchers track how much Lp(a) dr…
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New drug aims to tackle hidden heart risk factor
Disease control Recruiting nowThis study tests a new medicine called DII235 in 200 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants will receive either the drug or a placebo to see if it safely lowers their lipoprotein(a) levels over 6 to 12 months. The goal is …
Matched conditions: LIPOPROTEIN DISORDER
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New study probes link between Little-Known blood fat and heart risks
Knowledge-focused Recruiting nowThis study looks at how a specific blood fat called lipoprotein(a) might affect the stiffness of arteries, the health of blood vessel linings, and the heart's ability to pump. Researchers will follow 300 adults aged 18-75 for one year, measuring these factors and tracking any hea…
Matched conditions: LIPOPROTEIN DISORDER
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC